DUBLIN, Mar. 14, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Cardiac Biomarkers Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Cardiac Biomarkers Market is poised to grow at a CAGR of around 18.3% over the next decade to reach approximately $4.81 billion by 2025.
This industry report analyzes the global markets for Cardiac Biomarkers across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
Key Topics Covered:
1 Market Outline
1.1 Research Methodology
1.2 Market Trends
1.3 Regulatory Factors
1.4 Application Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Role of Biomarkers increased in the diagnosis of acute coronary syndrome (ACS)
3.1.2 Customized Solutions by manufacturers in cardiac biomarkers testing increased in recent past
3.1.3 Recent Technological Developments of Cardiac Biomarkers
3.1.4 Growth Opportunities/Investment Opportunities
3.4 Industry Attractiveness
4 Cardiac Biomarkers Market, By Location Of Testing
4.1 Laboratory Testing
4.1.1 Laboratory Testing Market Forecast to 2025 (US$ MN)
4.2 Point Of Care Testing
4.2.1 Point Of Care Testing Market Forecast to 2025 (US$ MN)
5 Cardiac Biomarkers Market, By Type
5.1.1 Myoglobin Market Forecast to 2025 (US$ MN)
5.2 Ischemia Modified Albumin
5.2.1 Ischemia Modified Albumin Market Forecast to 2025 (US$ MN)
5.3 Creatine Kinase (Ck-Mb)
5.3.1 Creatine Kinase (Ck-Mb) Market Forecast to 2025 (US$ MN)
5.4 Natriuretic Peptides (Bnp And Nt-Probnp)
5.4.1 Natriuretic Peptides (Bnp And Nt-Probnp) Market Forecast to 2025 (US$ MN)
5.5 Troponins (T,I)
5.5.1 Troponins (T,I) Market Forecast to 2025 (US$ MN)
5.6.1 D-Dimer Market Forecast to 2025 (US$ MN)
5.7 Other Types
5.7.1 Other Types Market Forecast to 2025 (US$ MN)
6 Cardiac Biomarkers Market, By Application
6.1 Acute Coronary Syndrome
6.1.1 Acute Coronary Syndrome Market Forecast to 2025 (US$ MN)
6.2 Myocardial Infarction
6.2.1 Myocardial Infarction Market Forecast to 2025 (US$ MN)
6.3.1 Atherosclerosis Market Forecast to 2025 (US$ MN)
6.4 Congestive Heart Failure
6.4.1 Congestive Heart Failure Market Forecast to 2025 (US$ MN)
6.5 Other Applications
6.5.1 Other Applications Market Forecast to 2025 (US$ MN)
7 Cardiac Biomarkers Market, By Geography
7.1 North America
7.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
7.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
7.3 Asia Pacific
7.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
7.4 Middle East
7.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
7.5 Latin America
7.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
7.6 Rest of the World (RoW)
7.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
8 Leading Companies
8.1 Randox Laboratories Ltd.
8.2 Boston Scientific
8.4 Siemens Healthcare Diagnostics
8.5 Bg Medicine Inc.
8.6 Critical Diagnostics
8.7 Abbott Diagnostics
8.8 Enzo Biochem Inc.
8.9 Sierra Resources International
8.10 Cisbio Bioassays
8.11 Response Biomedical Corp.
8.12 Alere Inc.
8.13 Bio-Rad Laboratories
8.15 Roche Holding Ag
8.16 Ortho Clinical Diagnostics
8.17 Thermo Fisher Scientific Inc.
8.18 Becton, Dickinson And Co.
8.19 Signosis Inc.
For more information about this report visit http://www.researchandmarkets.com/research/p98v8p/global_cardiac
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-481-billion-cardiac-biomarkers-market-analysis--trends-2016---industry-forecast-to-2025---research-and-markets-300423450.html
SOURCE Research and Markets